Medical/Pharmaceuticals
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index
SAN FRANCISCO and SUZHOU, China, Nov. 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-11-22 08:00
4848
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China
SUZHOU, China, Nov. 21, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Jiangsu Hengrui Pharmaceuticals ("Hengru...
2021-11-21 17:09
4377
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics
LONDON, Nov. 20, 2021 /PRNewswire/ -- Datar Cancer Genetics, a leading cancer research company focussed on early detection of cancers today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its blood test to detect early-stage Breast Cancer...
2021-11-20 08:00
6706
Vela Diagnostics expands automation options for SARS-CoV-2 RT-PCR Test
FAIRFIELD, N.J., Nov. 20, 2021 /PRNewswire/ -- Vela Diagnostics announced today that the ViroKey® SARS-CoV-2 RT-PCR Test v2.0 that received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), can now be used with the KingFisher FLEX system and Hamilton Microlab STA...
2021-11-20 01:15
4834
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing
Based on Highly-Purified Isomers of Tannic Acid and Acting as a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir Has Shown Significant Anti-Viral Properties with Minimal Observed Side Effects NEW TAIPEI CITY, Taiwan and TORRANCE, Calif., Nov. 20, 2021 /PRNewswire/ -- SyneuRx™ International, (Ta...
2021-11-20 01:00
3965
UAE to receive award from Parliamentary Assembly of the Mediterranean for Waterfalls Initiative
ROME, Nov. 19, 2021 /PRNewswire/ -- On Thursday November 18, in the Sala Protomoteca of the Campidoglio inRome, the United Arab Emirates, represented by Saif bin Zayed, Deputy Prime Minister and Minister of the Interior received an award from the Parliamentary Assembly of the Mediterranean (PAM) ...
2021-11-19 21:33
3946
Brii Biosciences Joins Hang Seng Composite Index
DURHAM, N.C. and BEIJING, Nov. 19, 2021 /PRNewswire/ -- Brii Biosciences
2021-11-19 19:06
4684
YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021
DUSSELDORF, Germany, Nov. 19, 2021 /PRNewswire/ -- Shenzhen YHLO Biotech Co., Ltd (688575.SSE), an innovative and steadfastly growing company of immunoassay solutions, presented its compact and automated chemiluminescence immunoassay (CLIA) analyzer iFlash 1200 at Medica 2021, a world-renowned tr...
2021-11-19 14:43
2717
Treating Patients Beyond Borders - Antengene Successfully Hosted Its First R&D Day
- Highlighted R&D Strategy and Broad Pipeline of 15 Programs including 10 with Worldwide Rights - ATG-010's First Approval in Asia transforms Antengene into a Commercial Entity, 10 Studies in ATG-010 being Conducted in Mainland China - Exciting ATG-008 (mTORC1/2 inhibitor) Signal, ATG-017 (ER...
2021-11-19 13:00
5148
EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider
- EQT Infrastructure has agreed to acquire Icon Group from a consortium including Goldman Sachs Asset Management, QIC and Pagoda. Goldman Sachs Asset Management will remain a minority shareholder as part of the transaction - Icon Group is Australia's largest vertically integrated cancer care...
2021-11-19 10:21
4149
Fiji based Omnicare Successfully Adopts the Digital Health Platform Jointly Provided by EnoviQ and InsureMO
SINGAPORE, Nov. 19, 2021 /PRNewswire/ -- EnoviQ, a health Insurance platform provider and eBaoTech, a digital Insurance solution provider are pleased to share their joint success in launching a digital health platform for Omnicare Pte. Ltd. (Omnicare) inFiji, to provide medical services to its na...
2021-11-19 10:00
3796
Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment
BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT. The investment demonstrates confidence in the stre...
2021-11-19 09:19
2947
Antengene Announces IND Approval in China for a Phase I/II Study of Selinexor (ATG-010) in Patients with Non-Hodgkin Lymphoma
SHANGHAI and Hong Kong, Nov. 19, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and onco...
2021-11-19 08:30
4197
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
SEOUL, South Korea, Nov. 18, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced that the US Food and Drug Administration (FDA) 510(k) has cleared its AI solution for breast cancer detection, 'Lunit INSIGHT MMG'. Along with its chest x-ray triaging solution 'Lunit INSIGHT C...
2021-11-18 22:00
2747
Betagenon co-founder publishes study demonstrating that pan-AMPK activator O304 acts as an exercise mimetic in aged mice
STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- Betagenon AB, a Sweden-based company focused on development of AMPK activator compounds, today announced the publication by co-founder Prof.Helena Edlund of a new study demonstrating that in aged mice the pan-AMPK activator O304 improves cardiac function a...
2021-11-18 21:32
1888
The Sigourney Award-2021 Honors Three Recipients With Distinguished International Prize for Advancing Psychoanalytic Thought
SEATTLE, Nov. 18, 2021 /PRNewswire/ -- The Sigourney Award annually rewards achievements that advance psychoanalytic thought and practice with international recognition and a substantial cash prize. This year, a panel of distinguished judges evaluated applications from five continents for The Si...
2021-11-18 21:14
2274
Treadwell Therapeutics Announces The Closing of a $91 Million Series B Financing
NEW YORK and HONG KONG, Nov. 18, 2021 /PRNewswire/ -- Treadwell Therapeutics ("Treadwell"), a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet needs in cancer, today announced the closing of an oversubscribed Series B financing, which raised more than$91...
2021-11-18 20:00
3553
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth
Dr. Steffen Wagner appointed as new Chief Executive Officer and Andreas Stickler as new Chief Financial Officer LONDON, Nov. 18, 2021 /PRNewswire/ -- ADVANZ PHARMA Corp. Limited ("ADVANZ PHARMA" or "the Company"), a specialty pharmaceutical company with a strategic focus on complex medicines in ...
2021-11-18 15:45
5478
China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China
SHANGHAI, Nov. 18, 2021 /PRNewswire/ -- China's pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data. TheChina specific findings of the CPhI Annual Report rankings[1] are released ahead of CPhI & P-MEC China - which will take pla...
2021-11-18 15:00
1877
First Subject Dosed in the U.S. Phase I Trial for ASC43F Only Half a Month after IND Approval by the U.S. FDA
SHANGHAI, Nov. 18, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), today announces dosing of the first subject in the U.S. Phase I trial for ASC43F, a first-in-class, fixed-dose combination (FDC) oral tablet with dual targets of thyroid h...
2021-11-18 08:30
3899
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 295 media titles]
2026-09-18 16:29Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
[Picked up by 289 media titles]
2026-09-15 11:00
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
[Picked up by 281 media titles]
2026-09-17 13:09
01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
[Picked up by 273 media titles]
2026-09-21 08:00Tetra Pak and Soy Excellence Center Asia Host Regional Soy Food and Beverage Programme in Thailand
[Picked up by 268 media titles]
2026-09-18 11:51
Most Read
Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
2026-09-15 11:00
11238
COSRX Brings Its 5 Peptide Lip Collection to Ulta Beauty Stores Offline
2026-09-18 22:00
9632
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
2026-09-17 13:09
8871
CLP Power Hosts AESIEAP CEO Conference 2026 in Hong Kong
2026-09-15 19:07
7105
